Patent Forecast® Catalog News For Companies For Investors For IP Attorneys Support About Us Menu

Cannabis is now legally being used to treat a wide variety of medical conditions, including chronic pain, alcoholism, drug addiction, anxiety, nausea (from chemotherapy) and epilepsy. Such a potent agent, which had been locked up for a century, is understandably attracting a lot of attention. Additionally, the fact that it is a botanical means that there is room for development in plant cultivation and processing, besides the traditional pharma areas of drug synthesis, formulation, processing and delivery. So there's a lot of room and a good material to work with.


Top 10 Corporate Owners


 
Issued Patent Count   
 
Published Pending Application Count

Corporation Patents and Published Applications Count
1. GW Pharmaceuticals
 
 
179
2. Inventor
 
 
170
3. Lunatech, Llc
 
 
129
4. Janssen Pharmaceutica Nv
 
 
38
5. Teewinot Technologies Limited
 
 
35
6. Mannkind Corporation
 
 
32
7. National Institutes of Health (NIH)
 
 
29
8. Yissum Research Development Company
 
 
27
9. AXIM Biotechnologies
 
 
26
10. Zynerba Pharmaceuticals, Inc.
 
 
24




Category and Tag Distribution

Category and Tags Patents and Published Applications
  • Compositions
  •  
    529
    133 Oral, 129 Topical, 95 Buccal/Nasal, 88 Vape, 55 Stability, 29 Other
  • Compounds
  •  
    432
    280 Pharmaceuticals, 95 other_cannabinoids, 57 derivatives
  • Cultivation
  •  
    109
    53 Farming, 37 Breeding, 19 GMO
  • Devices
  •  
    317
    272 Vapor/Smoke, 23 Other, 22 Transdermal
  • Food, Beverages, Supplements
  •  
    185
    84 Infused Beverage, 53 Food additives, 38 Food, 7 Infused Alcohol, 3 Oral supplements
  • Medical
  •  
    590
    230 Neurological/Psychiatric, 114 Other, 68 Pain, 64 Cancer, 60 Immune, 24 Ophthalmic, 17 Nausea, 11 Sexual, 2 Respiratory
  • Process
  •  
    409
    286 Extraction, 105 Analysis, 18 Decarboxylation
  • Processing
  •  
    66
    66 Synthesis/Conversion


    Recent Published Activity in Cannabis as of November 20, 2019